Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Juneau et al. v. The Procter & Gamble Co. and GSK Consumer Healthcare, Inc.
23-cv-5273, E.D. La.
(Sept. 2023)
DayQuil Severe, NyQuil Severe Cold & Flu, Theraflu Multi-Symptom Severe Cold/Severe Cold Cough, and other cold and flu medicines
Falsely marketing that medicines treat nasal congestion when the active ingredient (phenylephrine) is not an effective decongestant
Pending
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
Allegations: Misleadingly marketing products as if they treat symptoms of coughs and colds
Allegations: False natural claims
Allegations: False natural claims
Depending on how often you shave, this club may leave you razor burned.
When did the soap game get so dirty?
Green marketing claims you should think twice about.
Self-regulatory body calls supporting evidence behind superiority claims “materially flawed.”
What’s in a name? Sometimes not what you expect.